Table 2.
Positively selected sites in neuraminidase from viruses from different clusters
Dataset | Description | Number of sequences | Length of alignment (bp) | Number of sites under positive selection | Positively selected sites1 | ||
---|---|---|---|---|---|---|---|
SLAC | FEL | SLAC | FEL | ||||
2.1 | Avian strains | 137 | 1368 | 0 | 0 | ||
2.2 | North American swine strains | 171 | 1368 | 3 | 7 | 46TG, 396B,453T | 46TG,53T,75,127,285,339B,453T |
2.3 | Eurasian swine strains | 92 | 1368 | 0 | 1 | 75 | |
2.4 | Seasonal human strains | 1735 | 1371 | 5 | 6 | 84,151,222,275A,382 | 84,151,275A,344B,365BG,382 |
2.5 | Pandemic 2009 human strains | 1397 | 1368 | 0 | 2 | 35,453T |
1In this column, B indicates that the site lies in the B-cell antigenic regions [21]. G means that it is a potential glycosylation site. T indicates that the site lies in the T-cell antigenic regions [19]. We start numbering from the amino acids MNPN. A means that the site is associated with drug-resistance [7].